Cutaneous manifestations and considerations in COVID‐19 pandemic: a systematic review

F Seirafianpour, S Sodagar… - Dermatologic …, 2020 - Wiley Online Library
COVID‐19 had a great impact on medical approaches among dermatologist. This systematic
review focuses on all skin problems related to COVID‐19, including primary and secondary …

A compendium answering 150 questions on COVID‐19 and SARS‐CoV‐2

C Riggioni, P Comberiati, M Giovannini, I Agache… - Allergy, 2020 - Wiley Online Library
Abstract In December 2019, China reported the first cases of the coronavirus disease 2019
(COVID‐19). This disease, caused by the severe acute respiratory syndrome–related …

Eczema herpeticum in atopic dermatitis

S Traidl, L Roesner, J Zeitvogel, T Werfel - Allergy, 2021 - Wiley Online Library
Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases
leading to pruritic skin lesions. A subset of AD patients exhibits a disseminated severe HSV …

COVID-19 symptoms are attenuated in moderate-to-severe atopic dermatitis patients treated with dupilumab

B Ungar, JW Glickman, AK Golant, C Dubin… - The Journal of Allergy …, 2022 - Elsevier
Background In the SARS-CoV-2/COVID-19 pandemic, we need to understand the impact of
immunomodulatory medications on COVID-19 symptom severity in patients with …

How to manage COVID-19 vaccination in immune-mediated inflammatory diseases: an expert opinion by IMIDs study group

F Ferretti, R Cannatelli, M Benucci… - Frontiers in …, 2021 - frontiersin.org
Since March 2020, the outbreak of Sars-CoV-2 pandemic has changed medical practice and
daily routine around the world. Huge efforts from pharmacological industries have led to the …

Histologic features of long‐lasting chilblain‐like lesions in a paediatric COVID‐19 patient

AG Locatelli, ER Test, P Vezzoli… - Journal of the …, 2020 - ncbi.nlm.nih.gov
1 Patrı A, Gallo L, Guarino M, Fabbrocini G. Sexual transmission of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2): A new possible route of infection?. J Am Acad …

Clinical and immunological factors that distinguish COVID-19 from pandemic influenza A (H1N1)

JA Choreño-Parra, LA Jimenez-Alvarez… - Frontiers in …, 2021 - frontiersin.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), is a global health threat with the potential to cause …

[HTML][HTML] Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: position paper of Ärzteverband Deutscher …

L Klimek, O Pfaar, M Worm, T Eiwegger… - Allergologie …, 2020 - ncbi.nlm.nih.gov
Background: Since the beginning of the COVID-19 pandemic, the treatment of patients with
allergic and atopy-associated diseases has faced major challenges. Recommendations for …

COVID‐19 and immunological regulations–from basic and translational aspects to clinical implications

MP Schön, C Berking, T Biedermann… - JDDG: Journal der …, 2020 - Wiley Online Library
The COVID‐19 pandemic caused by SARS‐CoV‐2 has far‐reaching direct and indirect
medical consequences. These include both the course and treatment of diseases. It is …

Patients with specific skin disorders who are affected by COVID‐19: what do experiences say about management strategies? A systematic review

NN Nobari, A Goodarzi - Dermatologic therapy, 2020 - Wiley Online Library
In patients with specific dermatologic disorders who are affected by new corona virus, we
know little about disease course (underlying disease and new onset infection), and the most …